These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25561368)

  • 1. Systemic sclerosis in 2014: Advances in cohort enrichment shape future of trial design.
    Allanore Y; Distler O
    Nat Rev Rheumatol; 2015 Feb; 11(2):72-4. PubMed ID: 25561368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Autologous stem cell transplantation in systemic sclerosis].
    Henes JC; Wirths S; Kötter I
    Z Rheumatol; 2016 Oct; 75(8):762-769. PubMed ID: 27510996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell transplantation in systemic sclerosis: rationale and status report.
    Furst DE; Tyndall A
    Isr Med Assoc J; 2000 Dec; 2(12):935-7. PubMed ID: 11344779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic Sclerosis as an Indication for Autologous Hematopoietic Cell Transplantation: Position Statement from the American Society for Blood and Marrow Transplantation.
    Sullivan KM; Majhail NS; Bredeson C; Carpenter PA; Chatterjee S; Crofford LJ; Georges GE; Nash RA; Pasquini MC; Sarantopoulos S; Storek J; Savani B; St Clair EW
    Biol Blood Marrow Transplant; 2018 Oct; 24(10):1961-1964. PubMed ID: 29953945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Trial Design Issues in Systemic Sclerosis: an Update.
    Gordon JK; Domsic RT
    Curr Rheumatol Rep; 2016 Jun; 18(6):38. PubMed ID: 27146381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autologous hematopoietic stem cell transplantation for systemic sclerosis : Position statement of the stem cell therapy working party of the German Society of Rheumatology].
    Alexander T; Henes J; Distler JHW; Schmalzing M; Blank N; Kötter I; Hiepe F
    Z Rheumatol; 2020 Jun; 79(5):429-436. PubMed ID: 32322977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison between general rheumatologists and scleroderma experts with respect to following systemic sclerosis guidelines.
    Reed J; Pope J
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S40-6. PubMed ID: 26121522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow Transplantation Autoimmune Diseases Working Party and collaborating partners.
    Farge D; Burt RK; Oliveira MC; Mousseaux E; Rovira M; Marjanovic Z; de Vries-Bouwstra J; Del Papa N; Saccardi R; Shah SJ; Lee DC; Denton C; Alexander T; Kiely DG; Snowden JA
    Bone Marrow Transplant; 2017 Nov; 52(11):1495-1503. PubMed ID: 28530671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic stem cell transplantation for systemic sclerosis with rapid improvement in skin scores: is neoangiogenesis occurring?
    Burt RK; Oyama Y; Traynor A; Quigley K; Brush M; Rodriguez J; Barr WG
    Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S65-7. PubMed ID: 12931246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choosing appropriate patients with systemic sclerosis for treatment by autologous stem cell transplantation.
    Clements PJ; Furst DE
    J Rheumatol Suppl; 1997 May; 48():85-8. PubMed ID: 9150125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell transplantation in systemic sclerosis.
    van Laar JM; Sullivan K
    Curr Opin Rheumatol; 2013 Nov; 25(6):719-25. PubMed ID: 24047607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trial.
    Furst DE; Clements PJ; Wong WK; Mayes MD; Wigley F; White B; Weisman M; Barr W; Moreland L; Martin R; Medsger TA; Steen V; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Peter JB; Seibold JR
    Rheumatology (Oxford); 2001 Jun; 40(6):615-22. PubMed ID: 11426017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haematopoietic stem cell transplantation for poor-prognosis systemic sclerosis.
    van Laar JM; Naraghi K; Tyndall A
    Rheumatology (Oxford); 2015 Dec; 54(12):2126-33. PubMed ID: 25953700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell therapies for systemic sclerosis.
    Cipriani P; Ruscitti P; Giacomelli R
    Br J Haematol; 2015 Feb; 168(3):328-37. PubMed ID: 25376920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular Therapies in Systemic Sclerosis: Recent Progress.
    van Rhijn-Brouwer FC; Gremmels H; Fledderus JO; Radstake TR; Verhaar MC; van Laar JM
    Curr Rheumatol Rep; 2016 Feb; 18(2):12. PubMed ID: 26943351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innovative therapies for systemic sclerosis.
    Ong VH; Denton CP
    Curr Opin Rheumatol; 2010 May; 22(3):264-72. PubMed ID: 20190640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials in systemic sclerosis: lessons learned and outcomes.
    Matucci-Cerinic M; Steen VD; Furst DE; Seibold JR
    Arthritis Res Ther; 2007; 9 Suppl 2(Suppl 2):S7. PubMed ID: 17767745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous Stem cell Transplantation International Scleroderma (ASTIS) trial: hope on the horizon for patients with severe systemic sclerosis.
    van Laar JM; Farge D; Tyndall A
    Ann Rheum Dis; 2005 Oct; 64(10):1515. PubMed ID: 16162905
    [No Abstract]   [Full Text] [Related]  

  • 19. Adult stem cell treatment of scleroderma.
    Tyndall A; Furst DE
    Curr Opin Rheumatol; 2007 Nov; 19(6):604-10. PubMed ID: 17917542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic stem cell transplantation for systemic sclerosis: history and current status.
    Burt RK; Milanetti F
    Curr Opin Rheumatol; 2011 Nov; 23(6):519-29. PubMed ID: 21857226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.